Successful treatment of classic pyoderma gangrenosum with intralesional infliximab injection: A case report

Pyoderma gangrenosum (PG) is a rare dermatological disease characterized by the rapid development of painful skin ulcers. While systemic infliximab is considered a standard treatment for patients with PG, herein, we report our success with the use of intralesional infliximab in a 40-year-old woman w...

Full description

Saved in:
Bibliographic Details
Published in:Australasian journal of dermatology 2023-08, Vol.64 (3), p.e252-e255
Main Authors: Ahmadi, Kourosh, Aflaki, Elham, Akbarzade Jahromi, Mojgan, Dastgheib, Ladan
Format: Article
Language:English
Subjects:
Case reports
Infliximab
Monoclonal antibodies
Pyoderma
Pyoderma gangrenosum
Systemic lupus erythematosus
Tumor necrosis factor-α
Ulcers
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pyoderma gangrenosum (PG) is a rare dermatological disease characterized by the rapid development of painful skin ulcers. While systemic infliximab is considered a standard treatment for patients with PG, herein, we report our success with the use of intralesional infliximab in a 40-year-old woman with systemic lupus erythematosus (SLE) and PG.
ISSN:0004-8380
1440-0960
DOI:10.1111/ajd.14072